Morgan Lewis

European Court of Justice Finds Dominant Pharma Companies May Not Prevent Parallel Imports by Refusing to Meet “Ordinary” Orders from Wholesalers

By Antitrust Practice

LawFlash/Client Alert

  • published on:

    09/18/2008

  • by:

    Antitrust Practice

downloads/links:

pdfView LawFlash
print publication

The European Court of Justice (ECJ) ruled on September 16 that pharmaceutical companies that occupy a dominant position with respect to a particular drug may not refuse to meet “ordinary” orders from wholesalers in order to stop parallel imports.

For the full story, please view the PDF.